Target intelligence / Profile preview

Vaginal epithelial barrier function

Molecular classification
Other
01

Overview

The vaginal epithelial barrier function refers to the integrated defense mechanisms at the vaginal mucosa, comprising a multilayered stratified squamous epithelium, tight and desmosomal junctions, mucins, and resident immune cells and peptides[1][2][4][5][6]. This barrier protects against pathogen entry while allowing immune surveillance and maintenance of a symbiotic microbiota. The barrier’s integrity is influenced by hormonal status (notably estrogen), commensal microbiota (particularly Lactobacillus species), and is susceptible to disruption by pathogenic organisms, dysbiosis, inflammation, or direct chemical or mechanical injury. Loss of barrier function is associated with greater risk of infections (bacterial vaginosis, HIV, etc.) and inflammatory disorders. In summary: "Vaginal epithelial barrier function" is not a canonical molecular drug target; it is an emergent property of the vaginal epithelium involving multiple molecular, microbial, and immunological factors[1][2][4][5][6]. This entry is therefore considered incorrect as a molecular target by standard conventions.

Other names
Vaginal mucosal barrier functionVaginal barrierVaginal epithelial integrity
02

Biological functions

Barrier to pathogensMaintenance of vaginal homeostasisInteraction with microbiotaImmune defense in lower female genital tractRegulation of mucosal permeability
03

Disease associations

Infection (e.g., sexually transmitted infections, bacterial vaginosis, vulvovaginal candidiasis)Inflammation (e.g., vaginitis)Increased susceptibility to HIV and other sexually transmitted diseases
04

Safety considerations

Disrupted barrier increases infection risk (HIV, STIs)Inflammation and damage from pathogens or dysregulated immune responseDisruption as a consequence of certain infections or therapies (e.g., some detergents, antibiotics, HIV itself[5][6][7])
05

Biomarkers

sE-cadherin (marker of cell-cell adhesion breakdown)MMP-8 (matrix metalloproteinase 8)Markers of epithelial cell sheddingVaginal pH (indirect marker)Concentration of antimicrobial peptides (e.g., defensins, cathelicidins)

Beyond the preview

Go deeper on Vaginal epithelial barrier function.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaginal epithelial barrier function.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call